Labeling and description of prescription drugs to be modified next year

Published: 2003-07-30 07:00:00

Updated: 2003-07-30 07:00:00

The Korea Food and Drug Administration unveiled a plan to modify the present labeling and description of prescription drugs, in an effort to minimize the possible drug-dispensing-related accidents at pharmacy amid increasing prescription rates of ethical drugs in the wake of the oncoming system f...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK